Description
Ranibizumab is a monoclonal antibody that inhibits angiogenesis by inhibiting Vascular endothelial growth factor A, a mechanism similar to Bevacizumab.
DOSAGE FORMS AND STRENGTHS
• Single-use prefilled syringe designed to provide 0.05 mL for intravitreal injections:
– 10 mg/mL solution (LUCENTIS 0.5 mg)
– 6 mg/mL solution (LUCENTIS 0.3 mg)
• Single-use glass vial designed to provide 0.05 mL for intravitreal injections:
– 10 mg/mL solution (LUCENTIS 0.5 mg)
– 6 mg/mL solution (LUCENTIS 0.3 mg)
Pharma Services and Drug Inquiries
Our Pharma Division deals only with the best, GMP certified generics and branded medication for the export market. All our products are supported by strict adherence to quality and analysis certification.
Please note for the minimum order for Exports is of US$ 300. All orders will be subject to courier charges and supplies are normally dispatched through internationally accredited courier services.
Complete the form below to receive the no-obligation price quote.
Disclaimer
Note : We do not supply schedule-H (Example – narcotic drug or psychotropic drugs or anabolic steroids) and Anti- Abortion Drugs.
All Trademarks and Brands that appear on the website belong to their respective owners and South Delhi Pharma does not lay any claim on them we only provide Information. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.
